Stem Cell Treatment and Childhood Type 2 Diabetes

Please visit this new website www.childhoodtype2diabetes.com .  It is a great resource for Childhood Type 2 Diabetes. 

Diabetes Expert Dr. Dipnarine Maharaj

Diabetes Clinical Trial - Dr. Dipnarine Maharaj

Diabetes Clinical Trial - Dr. Dipnarine Maharaj

 

 

The Stem Cell Cancer Regenerative Medicine Research Foundation Inc. is seeking funding for research to uncover the inflammatory basis of degenerative diseases such as Diabetes Mellitus and to determine whether treating the inflammation will play a crucial role in altering the underlying biology of this disease which affects 24 million people in the United States and 241 million people worldwide. 

Diabetes Expert Dr. Dipnarine Maharaj M.D. FACP

 

Inflammation is part of the body’s normal healing response to injury. When blood vessels of  organs such as the pancreas suffer injury as a result of the effects of obesity, excessive sugar intake, smoking and abnormal cholesterol, for instance, the immune system as part of the inflammatory response dispatches cells to repair the damage. But in the face of a constant assault by such irritants over decades, possibly abetted by genetics that system can go into overdrive. Instead of protecting the vessels the inflammation becomes chronic and this leads to the body’s  decreased ability to  metabolize blood sugar and abnormal  insulin production by the pancreas which results in Diabetes. The inflammation of the blood vessels also  lead to the accumulation and potential rupture of arterial deposits called plaque that can cause heart attack and strokes which are common complications of Diabetes.

The goals of the Stem Cell Cancer Regenerative Medicine Research Foundation Inc. Is dedicated to taking actions that will: predict those patients at risk for development of the disease before the actual clinical onset, to prevent the disease; and study the use of stem cells for tissue repair.

The Stem Cell Cancer Regenerative Medicine Research Foundation’s support of the research being conducted by the South Florida Bone Marrow Stem Cell Transplant Institute under the direction of Medical Director, Dipnarine Maharaj, MD, FACP.

Dipnarine Maharaj - The Diabetes Clinical Trial Project:

The Diabetes Clinical Trial Project:



Diabetes Expert Dr. Dipnarine Maharaj M.D.

The South Florida Bone Marrow Stem Cell Transplant Institute would like to conduct a Diabetes Clinical Trial under the direction of Medical Director, Dipnarine Maharaj, MD, FACP.  The Diabetes Clinical Trial will involve the treatment of 60 diabetic patients ( 30 Type 1 & 30 Type  2) through a stem cell mobilization treatment.  Patient participants will be required to participate in initial screening processes before acceptance in the clinical trial to ensure that they are healthy enough to undergo the treatment protocol.

The patients selected to participate in the Diabetes Clinical Trial will undergo a series of stem cell mobilization treatments with stem cells for a period of 42 days(6 weeks).  Follow-up visits with the physician as well as all tests and examinations will be included as part of the Clinical Trial so that there is no cost to the patient participant.